ICD-10 Code C13.0: Malignant neoplasm of postcricoid region

Key Takeaways

ICD-10 Code C13.0 is the billable diagnosis code for malignant neoplasm of postcricoid region, a subsite of the hypopharynx

C13.0 is valid for FY2026 HIPAA-covered transactions and groups under MS-DRG v43.0

Use C13.0 only when pathology reports specifically identify the postcricoid region; choose C13.9 for unspecified hypopharynx malignancies

Pabau’s claims management software supports accurate ICD-10-CM code capture and claim submission workflows for oncology and specialist practices

ICD-10 Code C13.0 is a billable, four-character ICD-10-CM diagnosis code for malignant neoplasm of postcricoid region, a subsite of the hypopharynx located posterior to the cricoid cartilage. It falls within the C00-C96 neoplasm chapter of the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM).

Hypopharyngeal cancers account for roughly 3-5% of head and neck malignancies and carry some of the poorest five-year survival rates in that category, which makes accurate subsite coding important for both reimbursement and cancer registry data quality.

Practice management software like Pabau, including built-in claims management, helps oncology and ENT practices capture the correct diagnosis code at the point of documentation. This reduces downstream errors before a claim ever leaves the practice.

This reference covers code validity, anatomical context, the full C13 subcode family, Applicable To and Excludes notes, MS-DRG grouping, and step-by-step coding guidance for FY2026.

Code details at a glance

The table below summarizes the key administrative facts coders need before submitting any claim for malignant conditions, the same specificity requirement that applies to related neoplasm codes like M36.1.

What is the postcricoid region?

The hypopharynx is the lowermost portion of the pharynx (throat), extending from the level of the hyoid bone down to the opening of the esophagus. It sits immediately behind the larynx and is divided into three anatomical subsites: the postcricoid region, the aryepiglottic folds/arytenoids, and the posterior hypopharyngeal wall.

The postcricoid region occupies the area immediately posterior to the cricoid cartilage. It forms the anterior wall of the hypopharynx at its lower end and connects the hypopharynx to the cervical esophagus. Because it lies at this junction, tumors here frequently involve both the hypopharynx and the upper esophagus, which has direct implications for staging, surgical planning, and coding specificity.

Clinical significance for coders

Squamous cell carcinoma (SCC) is the predominant histological type in this region, consistent with hypopharyngeal malignancies broadly, and the same histology that drives much of the workload for dermatology practices tracking skin cancers. According to the WHO ICD-10 reference, postcricoid carcinoma is distinctly classified because its anatomical behavior, treatment approach, and prognosis differ from other hypopharyngeal subsites.

For coders, the postcricoid location matters because assigning C13.0 rather than the non-specific C13.9 reflects higher documentation quality and ensures the claim accurately represents the pathology documented in the operative or pathology report. The same specificity principle applies across other diagnostic categories, including H80.20.

• Postcricoid region: posterior to cricoid cartilage; anterior wall of lower hypopharynx
• Typical presentation: dysphagia, voice changes, cervical lymphadenopathy
• Predominant histology: squamous cell carcinoma (SCC)
• Clinical overlap: tumors may extend to cervical esophagus, requiring additional codes

C13.0 within the hypopharynx category

C13.0 is one of five billable subcodes within the C13 parent category. Selecting the right subcode depends entirely on the anatomical subsite documented by the treating clinician or pathologist. The AAPC ICD-10-CM code lookup and the official CMS tabular list both present these subcodes in the following hierarchy.

A coder’s first question should always be: does the clinical documentation specify the anatomical subsite? If the operative note or pathology report identifies the postcricoid region, C13.0 is the correct code. If the physician documents only “hypopharynx cancer” without further subsite detail, C13.9 applies. This same specificity discipline reduces audit risk for codes like H65.31 and supports accurate MS-DRG assignment.

Applicable To notes and Excludes notes for C13.0

Understanding the official notations in the ICD-10-CM tabular list is essential before assigning C13.0. These notes define what the code includes and what it explicitly does not cover.

Applicable To inclusions

The Applicable To section at the C13 parent level identifies clinical terms that map to the hypopharynx category as a whole. For C13.0 specifically, the code applies when the documented malignancy arises in the postcricoid area, including the pharyngoesophageal junction area when the predominant site is the postcricoid region rather than the cervical esophagus.

• Malignant neoplasm of postcricoid area
• Postcricoid carcinoma (when histologically confirmed as arising from the hypopharyngeal mucosa)

Excludes1 and Excludes2 notes

The C13 parent category carries Excludes1 and Excludes2 notes that apply to all subcodes, including C13.0. Excludes1 means the excluded code can never be used at the same time as C13.0. Excludes2 means the excluded condition may coexist and both codes can be reported together when clinically documented.

The aryepiglottic fold distinction is the most common source of error in this code family. The fold has two aspects: the hypopharyngeal aspect (C13.1) and the laryngeal aspect (C32.1). Always confirm which anatomical surface the pathologist describes before selecting between these two codes.

Digital intake forms that prompt physicians to specify anatomical subsite at the point of care reduce this type of ambiguity downstream.

MS-DRG grouping for hypopharynx cancer

When C13.0 is the principal diagnosis on an inpatient claim, it groups under the MS-DRG v43.0 system, typically within DRGs 011-013 (tracheostomy for face, mouth, and neck diagnoses, or laryngectomy, split by CC/MCC status) or DRGs 146-148 (ear, nose, mouth, and throat malignancy, split by CC/MCC status).

According to CMS ICD-10 coding resources, the specific DRG assignment depends on secondary diagnoses, procedures performed, and patient complications or comorbidities (CCs/MCCs). Practices should verify the exact DRG assignment against the current CMS IPPS final rule tables for FY2026, because DRG weights and grouping logic are updated annually.

For head and neck malignancies involving the pharynx, MS-DRGs typically fall within the ear, nose, mouth, and throat chapter of the DRG classification. Treatment context matters, since a patient admitted for radiation treatment planning carries a different DRG than one admitted for surgical resection (pharyngolaryngectomy).

HIPAA-compliant claim submission workflows must capture both the principal diagnosis and all relevant secondary diagnoses, so the claim groups to the most accurate and defensible DRG.

Coding guidelines and documentation requirements for ICD-10 Code C13.0

The ICD-10-CM Official Guidelines for Coding and Reporting (Section I, C, Chapter 2) govern how neoplasm codes are selected and sequenced. For C13.0 specifically, coders and clinicians should apply the following step-by-step process.

1. Confirm anatomical subsite in documentation. The pathology report, operative note, or multidisciplinary team (MDT) summary must explicitly state “postcricoid region.” If the documentation says “hypopharynx” without further specification, C13.9 applies.
2. Use the Neoplasm Table in the ICD-10-CM Alphabetic Index. Navigate to “Neoplasm, neoplastic – hypopharynx, hypopharyngeal NEC – postcricoid region” to locate C13.0. This prevents direct code-book look-up errors. The CDC/NCHS ICD-10-CM web tool provides a free, authoritative index search updated for FY2026.
3. Determine first-listed vs. additional code sequencing. For inpatient claims, sequence C13.0 as the principal diagnosis when the malignancy is the condition chiefly responsible for the admission. For outpatient encounters (chemotherapy, radiation, or surveillance), sequence the appropriate reason for the encounter first (e.g., Z51.11 for chemotherapy) and report C13.0 as an additional code per ICD-10-CM Section I.C.2 guidelines.
4. Report morphology and laterality where applicable. C13.0 does not have laterality options (the postcricoid region is a midline structure), so no laterality modifier is needed. Histological type (SCC versus adenocarcinoma) is not captured within C13.0 itself; a separate morphology code from the ICD-O-3 system may apply in cancer registry contexts.
5. Check for overlapping lesion criteria. If the pathology report documents that the tumor crosses from the postcricoid region into an adjacent subsite (such as the posterior hypopharyngeal wall), use C13.8 (overlapping sites) rather than C13.0.

Thorough physician documentation drives every step of this process. Practices that use Pabau Scribe, our AI scribe, can capture structured notes that include anatomical subsite detail, reducing the need for query-back loops between coders and clinicians.

How C13.0 fits into the broader head and neck cancer ICD-10 code landscape

Head and neck cancer coding spans the C00-C14 block of ICD-10-CM. Understanding where C13.0 sits within this broader structure helps coders navigate between adjacent codes and avoid misassignment, particularly for tumors near anatomical boundaries.

The postcricoid region’s proximity to the esophagus creates a recurring coding challenge. When the surgical or endoscopic report documents that the primary tumor originates in the postcricoid region but also involves the cervical esophagus, clinical judgment and documentation quality determine whether C13.0 or C15.3 (malignant neoplasm of cervical esophagus) becomes the principal code.

If both sites are equally involved and the origin is ambiguous, C13.8 (overlapping sites) may be the most defensible choice pending a physician query.

Oncology and ENT practices managing these complex cases benefit from structured patient records that link pathology reports, operative summaries, and staging information directly to the encounter record. This integrated documentation approach supports both accurate patient care management and cleaner claim submission.

Coding context and Pabau’s documentation workflow

Accurate oncology coding requires more than knowing the correct code. It requires a documentation workflow that captures subsite-specific detail from the first clinical encounter through final billing. Missed or vague documentation is the leading cause of code uncertainty in head and neck malignancy cases, just as it is for other site-specific tumors such as C51.0 (malignant neoplasm of labium majus).

Pabau supports oncology and ENT practices with compliance management workflows that flag incomplete documentation fields before claims are submitted. Structured note templates built around ICD-10-CM specificity requirements help clinicians capture anatomical subsite at the point of care, which directly feeds into clean claim preparation.

For practices managing high volumes of complex oncology claims, practice management platforms that integrate clinical documentation with billing reduce the coder-to-clinician query cycle that delays reimbursement.

Reduce coding errors before they reach the payer

Pabau helps oncology and ENT practices capture accurate ICD-10-CM codes at the point of clinical documentation, reducing claim rework and supporting compliant submission workflows.

Book a demo

Conclusion

Hypopharyngeal malignancies are low-volume but high-complexity from a coding standpoint. ICD-10 Code C13.0 is the correct, billable code for malignant neoplasm of the postcricoid region, valid for FY2026, and distinct from the other four C13 subcodes by virtue of a single documented anatomical detail: that the primary tumor arises posterior to the cricoid cartilage.

The most common errors with this code fall into three categories:

• Using C13.9 when documentation supports C13.0
• Confusing the hypopharyngeal and laryngeal aspects of the aryepiglottic fold
• Failing to apply C13.8 when a tumor genuinely crosses subsite boundaries

Structured documentation workflows, physician queries, and annual DRG verification eliminate the majority of these issues. Head and neck resections like pharyngolaryngectomy often involve surgical teams already using plastic surgery EMR software, which keeps ICD-10-CM documentation consistent across the surgical and oncology teams handling the same case.

Continue your research

Coding a related head and neck pathology? M31.2 covers lethal midline granuloma, a rare condition with its own subsite-specificity challenges.

Need a procedure code for supportive oncology care? J0702 covers betamethasone injections, commonly billed alongside cancer treatment plans.

Want a ready-made intake template? Pabau’s AUDIT-C questionnaire template gives practices a structured screening tool to pair with clinical documentation.

Frequently Asked Questions